CJC-1295 Without DAC Dosage Per Week: What Research Shows

CJC-1295 without DAC is most commonly researched at 100–300 mcg per injection, taken one to three times per day, which adds up to roughly 700–2,100 mcg per week. Many research protocols follow a 5-days-on, 2-days-off schedule, which lowers the weekly total by about 30%. The compound is not FDA-approved for human use, and the numbers below come from laboratory and community reports, not from large clinical trials.

What CJC-1295 Without DAC Actually Is

CJC-1295 without DAC is also called Mod GRF 1-29 or simply no DAC. It is a modified growth hormone-releasing hormone (GHRH) analog that has a short half-life of about 30 minutes. The without DAC label means it does not carry the Drug Affinity Complex that extends the half-life of the longer-acting version.

Because the peptide clears quickly, researchers typically inject it more often. The short half-life is the main reason weekly totals are divided into multiple small doses instead of one large weekly injection.

CJC-1295 without DAC has a half-life of roughly 30 minutes, so it is usually dosed multiple times per week rather than once weekly.

Typical CJC-1295 Without DAC Dosage Per Week in Research

Research doses for cjc-1295 no dac dosage generally fall between 100 mcg and 300 mcg per injection. Frequency ranges from once daily to three times daily. The table below shows how those choices translate into weekly totals.

Protocol style	Single dose	Injections per day	Days per week	Approximate weekly total
Low / conservative	100 mcg	1	5	500 mcg
Standard	100 mcg	2	5	1,000 mcg
Standard, 7 days	100 mcg	2	7	1,400 mcg
Higher range	200 mcg	2	5	2,000 mcg
Upper range	300 mcg	3	5	4,500 mcg

Weekly totals between 1,000 mcg and 2,000 mcg are the most frequently cited range in research forums. Very high weekly totals above 3,000 mcg are not supported by controlled human data. More is not automatically better, and higher doses may increase side effects such as flushing, hunger, and water retention.

How the Without-DAC Weekly Dose Compares to the DAC Version

The two versions of CJC-1295 are not interchangeable. The DAC form binds to albumin and stays active for days, while the without-DAC form clears within hours. That difference drives completely different dosing schedules.

Feature	CJC-1295 with DAC	CJC-1295 without DAC
Half-life	About 6–8 days	About 30 minutes
Typical research dose	1–2 mg per week	100–300 mcg per injection
Injection frequency	Once or twice weekly	1–3 times daily
Weekly total	1,000–2,000 mcg	700–2,100 mcg, sometimes higher
Common schedule	1 mg twice per week	5 days on, 2 days off

When people search for cjc-1295 with dac dosage, they often find weekly totals that look similar to the without-DAC version. The difference is that the DAC version is given once or twice per week, while the without-DAC version is split across many injections.

CJC-1295 with DAC is typically researched at 1–2 mg per week, while CJC-1295 without DAC is researched at 100–300 mcg per injection taken up to three times daily.

Stacking CJC-1295 Without DAC With Ipamorelin

CJC-1295 without DAC is frequently combined with ipamorelin, a growth hormone secretagogue. The two peptides act on different receptors, so researchers often study them together for a stronger combined signal.

A common research approach for cjc 1295 without dac and ipamorelin dosage is 100 mcg of each peptide per injection, given two to three times daily. Others use 100 mcg of CJC-1295 without DAC with 100–200 mcg of ipamorelin once daily before bed.

Search interest in cjc-1295 ipamorelin dosage per day reddit reflects how much confusion exists about timing. Many community posts recommend injecting before sleep to align with the body's natural nocturnal growth hormone pulse, but this timing has not been confirmed in large controlled trials.

Why Timing and Frequency Matter

Growth hormone release is pulsatile. Injecting a short-acting GHRH analog at the wrong time can blunt the natural pulse instead of adding to it. That is one reason the without-DAC version is often dosed several times per day rather than once weekly.

Fasting, recent exercise, and sleep quality all influence growth hormone output. Research on peptide dosing does not control for all of these variables, so reported results vary widely.

Bodybuilding, Fitness, and Community Protocols

Much of the online interest in cjc-1295 without dac dosage bodybuilding comes from athletes looking for recovery, lean mass, or fat-loss support. No large clinical trial has shown that CJC-1295 without DAC improves athletic performance or body composition in healthy adults.

The peptide is banned by the World Anti-Doping Agency (WADA) and is not approved by the FDA for any human use. Athletes subject to drug testing should assume that any use will be detected.

Community protocols often combine 5-days-on, 2-days-off schedules with 8–12 week cycles. These schedules are based on anecdote, not on published pharmacokinetic data.

People comparing notes on Reddit often mix up the two versions, which leads to widely different weekly totals. Always confirm whether a protocol refers to the DAC or the without-DAC form before comparing numbers.

Safety, Side Effects, and Legal Status

CJC-1295 without DAC is a research chemical. It is not FDA-approved for human use, and it is not sold as a prescription medication in the United States.

Reported side effects in community reports include injection-site reactions, flushing, increased hunger, and water retention. High doses may affect cortisol and prolactin levels, though human data are limited.

Because growth hormone pathways influence blood sugar, insulin sensitivity, and fluid balance, anyone with diabetes, heart disease, or hormone-sensitive conditions faces higher theoretical risk. Consulting a healthcare professional is essential before considering any peptide.

Quality also varies widely. Many research peptide vendors sell unverified products, and independent testing often finds underdosed or mislabeled vials.

CJC-1295 without DAC is not FDA-approved for human use in the United States, and no established safe or effective human dose exists.

COMMON QUESTIONS

Frequently Asked Questions

How much CJC-1295 without DAC should I take per week?

Research protocols most often use 100–300 mcg per injection, one to three times daily, which equals roughly 700–2,100 mcg per week. Many users follow a 5-days-on, 2-days-off schedule. CJC-1295 without DAC is not FDA-approved for human use, so no official weekly dose exists.

Is CJC-1295 without DAC the same as CJC-1295 with DAC?

No. CJC-1295 without DAC has a half-life of about 30 minutes and is injected up to three times daily. CJC-1295 with DAC lasts 6–8 days and is typically researched at 1–2 mg once or twice per week.

Can I stack CJC-1295 without DAC with ipamorelin?

Many research protocols pair CJC-1295 without DAC with ipamorelin, often at 100 mcg of each per injection. The combination is not FDA-approved, and no large clinical trial has confirmed its safety or effectiveness in humans. Talk with a healthcare professional before using any research peptide.